Evidence map›Paper›PMID 34112908›Full record

ArticleScientific reports2021

High-performance dialyzers and mortality in maintenance hemodialysis patients.

Masanori Abe, Ikuto Masakane, Atsushi Wada, Shigeru Nakai, Eiichiro Kanda, Kosaku Nitta, Hidetomo Nakamoto

Abstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. How should we treat acute kidney injury caused by renal congestion?Kidney research and clinical practice · 2023
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Masanori AbeThe Committee of Renal Data Registry, The Japanese Society for Dialysis Therapy, Tokyo, Japan. abe.masanori@nihon-u.ac.jp.
Ikuto MasakaneThe Committee of Renal Data Registry, The Japanese Society for Dialysis Therapy, Tokyo, Japan.
Atsushi WadaThe Committee of Renal Data Registry, The Japanese Society for Dialysis Therapy, Tokyo, Japan.
Shigeru NakaiThe Committee of Renal Data Registry, The Japanese Society for Dialysis Therapy, Tokyo, Japan.
Eiichiro KandaThe Committee of Renal Data Registry, The Japanese Society for Dialysis Therapy, Tokyo, Japan.
Kosaku NittaThe Committee of Renal Data Registry, The Japanese Society for Dialysis Therapy, Tokyo, Japan.
Hidetomo NakamotoThe Committee of Renal Data Registry, The Japanese Society for Dialysis Therapy, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Few data are available regarding the association of dialyzer type with prognosis. In Japan, dialyzers are classified as types I, II, III, IV, and V based on β

Indexed as

Agedbeta 2-MicroglobulinBiomarkersCause of DeathComorbidityFemaleHealth Care SurveysHumansJapanMaleMiddle AgedRegistriesRenal DialysisRenal InsufficiencyUreabeta 2-MicroglobulinBiomarkersUrea

Identifiers

PMID34112908
PMCPMC8192518

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.